Caravaca, A. S.
Centa, M.
Gallina, A. L.
Tarnawski, L.
Olofsson, P. S.
Funding for this research was provided by:
Hjärt-Lungfonden
Article History
Received: 20 December 2019
Accepted: 14 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: PSO is a co-founder and shareholder of Emune AB and ChAT Therapeutics, holds a faculty position the Feinstein Institute for Medical Research, and is an associate editor of <i>Bioelectronic Medicine</i>. MC is an employee of the Feinstein Institute for Medical Reserarch. ASC, ALG and LT declare no competing interests.